Castellan Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,700
Closed -$668K 60
2024
Q2
$668K Hold
4,700
0.32% 54
2024
Q1
$524K Sell
4,700
-2,230
-32% -$266K 0.27% 56
2023
Q4
$899K Sell
6,930
-21,945
-76% -$3.02M 0.56% 52
2023
Q3
$4.71M Sell
28,875
-4,985
-15% -$877K 3.31% 4
2023
Q2
$6.21M Sell
33,860
-9,285
-22% -$1.34M 3.97% 1
2023
Q1
$5.75M Sell
43,145
-11,970
-22% -$1.41M 3.93% 1
2022
Q4
$4.37M Sell
55,115
-570
-1% -$40.2K 3.05% 2
2022
Q3
$3.37M Buy
+55,685
New +$3.6M 2.62% 10

Other funds holding ACLS

Castellan Group's ACLS Position: Q3 2024 in Review

Castellan Group sold out of Axcelis (ACLS) in Q3 2024, closing a stake of 4,700 shares — an estimated $668K sold.

Castellan Group first reported a position in ACLS in Q3 2022 and held it in 8 quarters. The position peaked at $6.21M in Q2 2023. 368 funds tracked by Wall St. Rank hold ACLS as of Q3 2024.

  • Castellan Group reported no remaining Axcelis position as of Q3 2024 after selling out during the quarter.
  • Castellan Group sold 4,700 Axcelis shares in Q3 2024, an estimated $668K.
  • Castellan Group first reported a position in Axcelis in Q3 2022 and held it in 8 quarters.
  • Castellan Group's Axcelis position peaked at $6.21M in Q2 2023.
  • 368 funds tracked by Wall St. Rank held Axcelis as of Q3 2024.

Based on Castellan Group's 13F filing for Q3 2024, filed 25 Nov 2024.